| DBVT |
DBV Technologies S.A. |
Ordinary Shares, nominal value 0.10 euro per share |
10% |
$156,228,460 |
|
14,614,449 |
|
Adage Capital Management, L.P. |
30 Jun 2025 |
| MIST |
Milestone Pharmaceuticals Inc. |
Common Shares, no par value |
10% |
$17,318,128 |
|
8,659,064 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| CABA |
Cabaletta Bio, Inc. |
Common Stock, par value $0.00001 per share |
10% |
$14,404,128 |
|
9,002,580 |
|
Adage Capital Management, L.P. |
30 Jun 2025 |
| INO |
Inovio Pharmaceuticals, Inc. |
Common Stock, par value $0.001 per share |
10% |
$12,911,301 |
|
5,517,650 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| IMUX |
Immunic, Inc. |
Common stock, par value $0.0001 per share |
10% |
$8,697,850 |
+$7,537,012 |
10,479,337 |
+649% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| EQ |
Equillium, Inc. |
Common Stock, par value $0.0001 per share |
10% |
$8,596,850 |
|
6,012,624 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| KTTA |
Pasithea Therapeutics Corp. |
Common Stock, par value $0.0001 per share |
10% |
$2,050,179 |
|
2,329,749 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| IBIO |
iBio, Inc. |
Common Stock, par value $0.001 per share |
10% |
$1,795,528 |
|
2,181,422 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| MNPR |
Monopar Therapeutics |
Common Stock, par value $0.001 per share |
9.9% |
$26,706,121 |
|
599,195 |
|
Adage Capital Management, L.P. |
31 Dec 2024 |
| TRAW |
Traws Pharma, Inc. |
Common Stock, par value $0.01 per share |
9.1% |
$1,175,300 |
+$644,000 |
730,000 |
+121% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| GPACU |
General Purpose Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
8.7% |
$18,018,000 |
|
1,800,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| NBR |
Nabors Industries Ltd. |
Common Shares, par value $0.05 per share |
8% |
$68,418,000 |
|
1,260,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
|
Talon Capital Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
7.9% |
|
|
2,025,000 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| TNGX |
Tango Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
7.9% |
$124,643,107 |
+$95,138,857 |
10,607,924 |
+322% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| EVOX |
Evolution Global Acquisition Corp |
Class A Ordinary Shares, par value $0.0001 per share |
7.9% |
$18,654,300 |
|
1,890,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| DNMX |
Dynamix Corp III |
Class A Ordinary Shares, par value $0.0001 per share |
7.8% |
$15,576,750 |
|
1,575,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| LATAU |
Galata Acquisition Corp. II |
Class A Ordinary Shares, par value $0.0001 per share |
7.8% |
$13,473,000 |
|
1,350,000 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| DYOR |
Insight Digital Partners II |
Class A Ordinary Shares, par value $0.0001 per share |
7.8% |
$13,365,000 |
|
1,350,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| KBONU |
Karbon Capital Partners Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$27,243,000 |
|
2,700,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| CRAN |
Crane Harbor Acquisition Corp. II |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$26,703,000 |
|
2,700,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| AEAQU |
Activate Energy Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$18,018,000 |
|
1,800,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| VACI |
Viking Acquisition Corp I |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$17,748,000 |
|
1,800,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| TWLV |
Twelve Seas Investment Co III |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$13,311,000 |
|
1,350,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
|
Highview Merger Corp. |
Class A ordinary shares, par value $0.0001 per share |
7.6% |
|
|
1,800,000 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| HCACU |
Hall Chadwick Acquisition Corp |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$16,248,600 |
|
1,620,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| TDWD |
Tailwind 2.0 Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$13,324,500 |
|
1,350,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
|
Safeguard Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
|
|
1,800,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| LFACU |
Leapfrog Acquisition Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$11,255,625 |
|
1,125,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| OTGAU |
OTG Acquisition Corp. I |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$18,126,000 |
|
1,800,000 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| CNTA |
Centessa Pharmaceuticals plc |
Ordinary shares, nominal value 0.002 GBP per share |
7.5% |
$243,348,750 |
+$39,576,000 |
10,035,000 |
+19% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| IGACU |
Invest Green Acquisition Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
7.4% |
$13,540,500 |
|
1,350,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| DSACU |
Daedalus Special Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
7% |
$18,072,000 |
|
1,800,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| ADGM |
Adagio Medical Holdings, Inc. |
Common Stock, par value $0.0001per share |
6.9% |
$2,085,247 |
+$467,363 |
1,058,501 |
+29% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| VHCPU |
Vine Hill Capital Investment Corp. II |
Class A Ordinary Shares, par value $0.0001 per share |
6.8% |
$15,828,750 |
|
1,575,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| APXT |
Apex Treasury Corp |
Class A Ordinary Shares, par value $0.0001 per share |
6.5% |
$22,252,500 |
|
2,250,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| CCXIU |
Churchill Capital Corp XI |
Class A Ordinary Shares, par value $0.0001 per share |
6.4% |
$27,756,000 |
|
2,700,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
|
SilverBox Corp V |
Class A Ordinary Shares, par value $0.0001 per share |
6.4% |
|
|
1,750,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| BCSS |
Bain Capital GSS Investment Corp. |
Class A Ordinary Shares, $0.0001 par value |
6.4% |
$30,390,000 |
|
3,000,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| NERV |
Minerva Neurosciences, Inc. |
Common Stock, par value $0.0001 per share |
6.4% |
$11,777,700 |
|
2,838,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| PRQR |
ProQR Therapeutics N.V. |
Ordinary Shares, nominal value 0.04 euro per share |
6.3% |
$13,467,954 |
-$3,060,326 |
6,601,938 |
-19% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| LZM |
Lifezone Metals Ltd |
Ordinary Shares, par value $0.0001 per share |
5.8% |
$27,963,922 |
|
5,075,122 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| RLMD |
Relmada Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.8% |
$18,062,100 |
|
4,270,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| EYPT |
EyePoint, Inc. |
Common Stock, par value $0.001 per share |
5.7% |
$81,921,000 |
-$14,986,000 |
4,700,000 |
-15% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| DRUG |
Bright Minds Biosciences Inc. |
Common Shares, no par value |
5.6% |
$24,005,770 |
|
395,743 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| MCB |
Metropolitan Bank Holding Corp. |
Common Stock, par value $0.01 per share |
5.4% |
$42,721,816 |
|
559,479 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| LPCVU |
Launchpad Cadenza Acquisition Corp I |
Class A Ordinary Shares, par value $0.0001 per share |
5.4% |
$12,550,000 |
|
1,250,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| ADACU |
American Drive Acquisition Co |
Class A Ordinary Shares, par value $0.0001 per share |
5.4% |
$12,500,000 |
|
1,250,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| WVE |
Wave Life Sciences Ltd. |
Ordinary Shares, no par value |
5.4% |
$139,157,787 |
-$74,376,843 |
9,786,061 |
-35% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| NPB |
NORTHPOINTE BANCSHARES INC |
Common Stock, no par value |
5.2% |
$30,643,296 |
|
1,794,104 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| MGTX |
MeiraGTx Holdings plc |
Ordinary Shares, par value $0.00003881 per share |
5.2% |
$34,439,077 |
|
4,184,578 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| KPTI |
Karyopharm Therapeutics Inc. |
Common Stock, par value $0.0001 per share |
5.2% |
$24,500,946 |
|
6,551,055 |
|
Adage Capital Management, L.P. |
31 Dec 2024 |
| TERN |
Terns Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
5.1% |
$196,914,000 |
|
5,550,000 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| SDRL |
Seadrill Ltd |
Common Shares, par value $0.01 per share |
5% |
$96,188,466 |
-$32,557,932 |
3,138,286 |
-25% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| MNRO |
Monro, Inc. |
Common Stock, par value $0.01 per share |
5% |
$31,185,000 |
-$15,010,380 |
1,500,000 |
-32% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| CDTX |
Cidara Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
5% |
$55,594,000 |
+$5,559,400 |
1,100,000 |
+11% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| ACRS |
Aclaris Therapeutics, Inc. |
Common Stock, par value $0.00001 per share |
4.9% |
$10,028,474 |
-$5,554,080 |
5,278,144 |
-36% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| FULC |
Fulcrum Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
4.5% |
$22,374,400 |
-$19,844,400 |
2,432,000 |
-47% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| JANX |
Janux Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
4.3% |
$63,503,750 |
-$13,499,262 |
2,525,000 |
-18% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| ZVRA |
Zevra Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4% |
$21,159,750 |
-$13,551,750 |
2,225,000 |
-39% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| ALGS |
Aligos Therapeutics, Inc. |
Voting Common Stock, par value $0.0001 per share |
3.9% |
$1,514,100 |
-$829,150 |
210,000 |
-35% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| PRAX |
Praxis Precision Medicines, Inc. |
Common Stock, par value $0.0001 per share |
3.8% |
$278,444,535 |
-$98,033,194 |
965,313 |
-26% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| ZEO |
Zeo Energy Corp. |
Class A Common Stock, par value $0.0001 per share |
3.2% |
$1,915,200 |
|
760,000 |
|
Adage Capital Management, L.P. |
30 Jun 2025 |
| ENSC |
Ensysce Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
3.2% |
$167,353 |
|
74,711 |
0% |
Adage Capital Management, L.P. |
30 Jun 2025 |
| ENGN |
enGene Holdings Inc. |
Common Shares, with no par value per share |
3% |
$6,115,072 |
|
1,528,768 |
|
Adage Capital Management, L.P. |
31 Dec 2024 |
| URGN |
UroGen Pharma Ltd. |
Ordinary Shares, par value NIS 0.01 per share |
2.8% |
$13,740,520 |
-$17,765,685 |
1,277,000 |
-56% |
Adage Capital Management, L.P. |
31 Mar 2025 |
| SLNO |
SOLENO THERAPEUTICS INC |
Common Stock, par value $0.001 per share |
2.6% |
$94,746,538 |
-$146,988,629 |
1,401,576 |
-61% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| AEVA |
Aeva Technologies, Inc. |
Common Stock, par value $0.0001 per share |
2.6% |
$10,062,440 |
|
1,401,454 |
|
Adage Capital Management, L.P. |
31 Mar 2025 |
| AMLX |
Amylyx Pharmaceuticals, Inc. |
Common Stock, $0.0001 par value per share |
2.5% |
$33,296,889 |
-$48,436,878 |
2,777,055 |
-59% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| TCRX |
TScan Therapeutics, Inc. |
Voting Common Stock, par value $0.0001 per share |
2.5% |
$1,957,500 |
|
1,350,000 |
|
Adage Capital Management, L.P. |
30 Jun 2025 |
| KPTI |
Karyopharm Therapeutics Inc. |
Common Stock, par value $0.0001 per share |
2.4% |
$3,140,132 |
|
436,736 |
|
Adage Capital Management, L.P. |
31 Dec 2025 |
| BBOT |
BridgeBio Oncology Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
1.9% |
$17,226,651 |
|
1,487,621 |
|
Adage Capital Management, L.P. |
30 Sep 2025 |
| SLDB |
Solid Biosciences Inc. |
Common Stock $0.001 par value per share |
1.8% |
$7,896,000 |
-$14,664,000 |
1,400,000 |
-65% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| MREO |
Mereo BioPharma Group plc |
Ordinary Shares, nominal value 0.003 GBP per share |
1.1% |
$22,194,866 |
|
8,503,780 |
|
Adage Capital Management, L.P. |
31 Mar 2025 |
| ETHM |
Dynamix Corp |
Class A Ordinary Shares, par value $0.0001 per share |
0.75% |
$1,301,250 |
-$12,752,250 |
125,000 |
-91% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| LXEO |
Lexeo Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
0.7% |
$875,667 |
-$7,255,716 |
237,953 |
-89% |
Adage Capital Management, L.P. |
31 Mar 2025 |
| GLYC |
GLYCOMIMETICS INC |
Ordinary Shares, par value $0.001 per share |
0.37% |
|
|
50,912 |
|
Adage Capital Management, L.P. |
20 Jun 2025 |
| STR |
Sitio Royalties Corp. |
Class A Common Stock, par value $0.0001 per share |
0% |
$0 |
-$113,492,736 |
0 |
-100% |
Adage Capital Management, L.P. |
30 Sep 2025 |
| INZY |
Inozyme Pharma, Inc. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
|
0 |
|
Adage Capital Management, L.P. |
30 Jun 2025 |
| TARA |
Protara Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
-$9,720,000 |
0 |
-100% |
Adage Capital Management, L.P. |
31 Mar 2025 |
| ABEO |
ABEONA THERAPEUTICS INC. |
Common Stock, par value $0.01 per share |
0% |
$0 |
-$27,246,750 |
0 |
-100% |
Adage Capital Management, L.P. |
31 Dec 2025 |
| ETNB |
89bio, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
-$133,734,529 |
0 |
-100% |
Adage Capital Management, L.P. |
29 Oct 2025 |